Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Short term Debt (2016 - 2025)

Historic Short term Debt for Bruker (BRKR) over the last 16 years, with Q3 2025 value amounting to $24.3 million.

  • Bruker's Short term Debt fell 2591.46% to $24.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.3 million, marking a year-over-year decrease of 2591.46%. This contributed to the annual value of $32.5 million for FY2024, which is 7318.48% down from last year.
  • Latest data reveals that Bruker reported Short term Debt of $24.3 million as of Q3 2025, which was down 2591.46% from $55.7 million recorded in Q2 2025.
  • Over the past 5 years, Bruker's Short term Debt peaked at $121.2 million during Q4 2023, and registered a low of $11.0 million during Q1 2022.
  • Its 5-year average for Short term Debt is $63.8 million, with a median of $37.7 million in 2025.
  • In the last 5 years, Bruker's Short term Debt surged by 634117.65% in 2021 and then crashed by 8985.24% in 2022.
  • Quarter analysis of 5 years shows Bruker's Short term Debt stood at $112.4 million in 2021, then crashed by 83.36% to $18.7 million in 2022, then surged by 548.13% to $121.2 million in 2023, then plummeted by 73.18% to $32.5 million in 2024, then decreased by 25.23% to $24.3 million in 2025.
  • Its Short term Debt stands at $24.3 million for Q3 2025, versus $55.7 million for Q2 2025 and $37.7 million for Q1 2025.